Atlas Trials

Repurposing alpha1 Noradrenergic Antagonists for Alcoholism Treatment

Clinical trial NCT02966340 · COMPLETED

Trial details

NCT number
NCT02966340
Sponsor
University of Wisconsin, Madison
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Alcoholism
Start date
2016-11-01
Primary completion
2018-03-12
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.